ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 2

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases

Akbar Mohammad Hosseini, Jafar Majidi*, Behzad Baradaran*, Mehdi Yousefi

Adv Pharm Bull. 2015;5(5): 605-614. doi: 10.15171/apb.2015.082

PMCID: PMC4708030 PMID: 26793605 Scopus ID: 84954092442

Article

PDF

XML

Cited By:

Original Research

2. IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells

Zeynab Aliyari, Sara Soleimanirad, Manizheh Sayyah Melli, Hamid Tayefi Nasrabadi, Hojjatollah Nozad Charoudeh*

Adv Pharm Bull. 2015;5(5): 615-619. doi: 10.15171/apb.2015.083

PMCID: PMC4708031 PMID: 26793606 Scopus ID: 84954090852

Article

PDF

XML

Cited By:

Research Article

3. Helicobacter pylori Recombinant CagA Regulates Th1/Th2 Balance in a BALB/c Murine Model

Nafiseh Paydarnia, Behzad Mansoori , Davoud Esmaeili, Tohid Kazemi , Mahyar Aghapour , Khalil Hajiasgharzadeh, Nazila Alizadeh, Behzad Baradaran*

Adv Pharm Bull. 2020;10(2): 264-270. doi: 10.34172/apb.2020.031

PMCID: PMC7191242 PMID: 32373495 Scopus ID: 85088702517

Article

PDF

Full Text

XML

Cited By:

Research Article

4. Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis

Mehrdad Gholamzad , Hussein Baharlooi , Mehdi Shafiee Ardestani, Zeinab Seyedkhan, Maryam Azimi*

Adv Pharm Bull. 2021;11(3): 505-513. doi: 10.34172/apb.2021.058

PMCID: PMC8421634 PMID: 34513625 Scopus ID: 85108911841

Article

PDF

Full Text

XML

Cited By:

Review Article

5. Effect of Nicotine on Immune System Function

leila Mahmoudzadeh , Seyyed Meysam Abtahi Froushani, Marjan Ajami, Maryam Mahmoudzadeh*

Adv Pharm Bull. 2023;13(1): 69-78. doi: 10.34172/apb.2023.008

PMCID: PMC9871277 PMID: 36721811

Article

PDF

Full Text

XML

Cited By:

Research Article

6. Electrosprayed Nanoparticles Containing Hydroalcoholic Extract of Echinacea purpurea (L.) Moench Stimulates Immune System by Increasing Inflammatory Factors in Male Wistar Rats

Fatemeh Mehdizadeh , Ramin Mohammadzadeh, Hossein Nazemiyeh, Mehran Mesgari-Abbasi, Mohammad Barzegar-Jalali, Morteza Eskandani* , Khosro Adibkia*

Adv Pharm Bull. 2023;13(2): 283-289. doi: 10.34172/apb.2023.031

PMCID: PMC10278220 PMID: 37342366

Article

PDF

Full Text

XML

Cited By:

Review Article

7. Nanovaccines against Cervical Cancer: Reliable Strategies to Circumvent Limitations of Traditional Therapeutic Vaccines

Enwa Felix Oghenemaro , Safia Obaidur Rab, Ebraheem Abdu Musad Saleh* , Asmaa F. Kassem, Jasur Rizaev, Deepak Nathiya, Parjinder Kaur, M. Ravi Kumar, Karam Kadhim, Ahmed M. Hashim

Adv Pharm Bull. 2025;15(1): 46-59. doi: 10.34172/apb.43712

Article

PDF

Full Text

XML

Cited By:

Short Communication

8. Agaricus bisporus Mannose-Binding Protein Stimulates the Innate Immune Cells

Wangsa Tirta Ismaya , Agung Heru Karsono , Olivia Mayasari Tandrasasmita , Raymond Rubianto Tjandrawinata , Heni Rachmawati*

Adv Pharm Bull. 2024;14(4): 944-950. doi: 10.34172/apb.43767

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Original Article

9. Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma

Maryam Samareh-Salavatipour , Shirin Tavakoli , Maryam Barkhordar, Iman Seyhoun*, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Tahereh Bakhtiari, Ardeshir Ghavamzadeh, Javad Verdi* , Mohammad Ahmadvand*

Adv Pharm Bull. 2025;15(1): 143-153. doi: 10.34172/apb.43859

Article

PDF

Full Text

XML

Cited By:

Review Article

10. Lung Cancer Immunotherapy Approaches: From Clinical Testing to Future Advances

Mayuri Bhattacharyya , Suktilang Majaw*

Adv Pharm Bull. 2025;15(2): 326-340. doi: 10.34172/apb.025.45104

Article

PDF

XML

Cited By: